Immunodermatology

Top Story

Ruxolitinib cream improves repigmentation of vitiligo at 52 weeks

October 21, 2019

UCB reports bimekizumab response rates superior to Stelara in psoriasis

October 18, 2019
Treatment with bimekizumab, an interleukin-17A and IL-17F inhibitor in adults with chronic plaque psoriasis, resulted in at least a 90% improvement in the Psoriasis Area…
Meeting News

Bermekimab improves all disease measures of atopic dermatitis in phase 2 study

October 16, 2019
Bermekimab, which neutralizes interleukin-1 alpha, improved all disease measures of atopic dermatitis, including a large reduction in pruritus, according to phase 2…
Meeting News

Oral JAK inhibitor improves alopecia areata severity

October 15, 2019
Patients with moderate to severe alopecia areata who were assigned to CTP-543, an oral Janus kinase inhibitor from Concert Pharmaceuticals, achieved a 50% relative…
More Headlines »
Healio Jobs